Literature DB >> 23918679

Associations between allergies and risk of hematologic malignancies: results from the VITamins and lifestyle cohort study.

Mazyar Shadman1, Emily White, Anneclaire J De Roos, Roland B Walter.   

Abstract

Immune dysregulations associated with allergies may affect cancer cell biology but studies on the relationship between allergies and risk of hematologic malignancies (HM) yielded inconsistent results. Herein, we used the vitamins and Lifestyle (VITAL) cohort to examine this association. From 2000 to 2002, 66,212 participants, aged 50-76, completed a baseline questionnaire on cancer risk factors, medical conditions, allergies, and asthma. Through 2009, incident HMs (n = 681) were identified via linkage to the surveillance, epidemiology, and end results cancer registry. After adjustment for factors possibly associated with HMs, a history of airborne allergy was associated with increased risk of HMs (hazard ratio [HR] = 1.19 [95% confidence interval: 1.01-1.41], P = 0.039) in Cox proportional hazards models. This association was limited to allergies to plants/grass/trees (HR = 1.26 [1.05-1.50], P = 0.011) and was strongest for some mature B-cell lymphomas (HR = 1.50 [1.14-2.00], P = 0.005). Gender-stratified analyses revealed that the associations between airborne allergies overall and those to plants, grass, and trees were only seen in women (HR = 1.47 [1.14-1.91], P = 0.004; and HR = 1.73 [1.32-2.25], P < 0.001) but not men (HR = 1.03 [0.82-1.29], P = 0.782; and HR = 0.99 [0.77-1.27], P = 0.960). Together, our study indicates a moderately increased risk of HMs in women but not men with a history of allergies to airborne allergens, especially to plant, grass, or trees.
Copyright © 2013 Wiley Periodicals, Inc.

Entities:  

Mesh:

Substances:

Year:  2013        PMID: 23918679      PMCID: PMC4001851          DOI: 10.1002/ajh.23564

Source DB:  PubMed          Journal:  Am J Hematol        ISSN: 0361-8609            Impact factor:   10.047


  22 in total

1.  Cancer; a biological approach. I. The processes of control.

Authors:  M BURNET
Journal:  Br Med J       Date:  1957-04-06

2.  Autoimmune diseases, asthma and risk of haematological malignancies: a nationwide case-control study in Sweden.

Authors:  Karin C Söderberg; Fredrik Jonsson; Ola Winqvist; Lars Hagmar; Maria Feychting
Journal:  Eur J Cancer       Date:  2006-09-01       Impact factor: 9.162

Review 3.  An overview of the association between allergy and cancer.

Authors:  Michelle C Turner; Yue Chen; Daniel Krewski; Parviz Ghadirian
Journal:  Int J Cancer       Date:  2006-06-15       Impact factor: 7.396

Review 4.  The association between atopy and childhood/adolescent leukemia: a meta-analysis.

Authors:  Amy M Linabery; Anne M Jurek; Sue Duval; Julie A Ross
Journal:  Am J Epidemiol       Date:  2010-03-12       Impact factor: 4.897

5.  Markers of B-cell activation in relation to risk of non-Hodgkin lymphoma.

Authors:  Anneclaire J De Roos; Dana K Mirick; Kerstin L Edlefsen; Andrea Z LaCroix; Kenneth J Kopecky; Margaret M Madeleine; Larry Magpantay; Otoniel Martínez-Maza
Journal:  Cancer Res       Date:  2012-07-30       Impact factor: 12.701

6.  Birth order, allergies and lymphoma risk: results of the European collaborative research project Epilymph.

Authors:  Nikolaus Becker; Silvia de Sanjose; Alexandra Nieters; Marc Maynadié; Lenka Foretova; Pier Luigi Cocco; Anthony Staines; Tomas Alvaro; Martine Vornanen; Paul Brennan; Paolo Boffetta
Journal:  Leuk Res       Date:  2007-05-03       Impact factor: 3.156

7.  Risk of multiple myeloma and monoclonal gammopathy of undetermined significance among white and black male United States veterans with prior autoimmune, infectious, inflammatory, and allergic disorders.

Authors:  Linda Morris Brown; Gloria Gridley; David Check; Ola Landgren
Journal:  Blood       Date:  2008-01-31       Impact factor: 22.113

8.  Immunoglobulin E levels and risk of lymphoma in a case-control study in Spain.

Authors:  Lis Ellison-Loschmann; Yolanda Benavente; Jeroen Douwes; Enric Buendia; Rebecca Font; Tomás Alvaro; Manolis Kogevinas; Silvia de Sanjosé
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2007-07       Impact factor: 4.254

9.  Allergy and risk of childhood acute lymphoblastic leukemia: a population-based and record-based study.

Authors:  Jeffrey S Chang; Yi-Wen Tsai; Chia-Rung Tsai; Joseph L Wiemels
Journal:  Am J Epidemiol       Date:  2012-11-20       Impact factor: 4.897

10.  Allergic conditions and risk of hematological malignancies in adults: a cohort study.

Authors:  Karin C Söderberg; Lars Hagmar; Judith Schwartzbaum; Maria Feychting
Journal:  BMC Public Health       Date:  2004-11-04       Impact factor: 3.295

View more
  7 in total

Review 1.  Epidemiology of MPN: what do we know?

Authors:  L A Anderson; M F McMullin
Journal:  Curr Hematol Malig Rep       Date:  2014-12       Impact factor: 3.952

2.  Farm characteristics, allergy symptoms, and risk of non-hodgkin lymphoid neoplasms in the agricultural health study.

Authors:  Jonathan N Hofmann; Jane A Hoppin; Charles F Lynch; Jill A Poole; Mark P Purdue; Aaron Blair; Michael C Alavanja; Laura E Beane Freeman
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2015-01-12       Impact factor: 4.254

3.  Allergies and Asthma in Relation to Cancer Risk.

Authors:  Elizabeth D Kantor; Meier Hsu; Mengmeng Du; Lisa B Signorello
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2019-06-05       Impact factor: 4.254

4.  Allergic diseases and risk of hematopoietic malignancies in a cohort of postmenopausal women: a report from the Iowa Women's Health Study.

Authors:  Amy M Linabery; Anna E Prizment; Kristin E Anderson; James R Cerhan; Jenny N Poynter; Julie A Ross
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2014-06-24       Impact factor: 4.254

5.  IL-17 producing mast cells promote the expansion of myeloid-derived suppressor cells in a mouse allergy model of colorectal cancer.

Authors:  Xiaowei Chen; Michael J Churchill; Karan K Nagar; Yagnesh H Tailor; Timothy Chu; Brittany S Rush; Zhengyu Jiang; Edwin B C Wang; Bernhard W Renz; Hongshan Wang; Ming Chiu Fung; Daniel L Worthley; Siddhartha Mukherjee; Timothy C Wang
Journal:  Oncotarget       Date:  2015-10-20

6.  Upregulation of histamine receptor H1 promotes tumor progression and contributes to poor prognosis in hepatocellular carcinoma.

Authors:  Jing Zhao; Yiran Hou; Chun Yin; Jing Hu; Tian Gao; Xiaojun Huang; Xiaohong Zhang; Jinliang Xing; Jiaze An; Shaogui Wan; Jibin Li
Journal:  Oncogene       Date:  2019-11-18       Impact factor: 9.867

Review 7.  AllergoOncology: Role of immune cells and immune proteins.

Authors:  Mario Di Gioacchino; Loredana Della Valle; Alessandro Allegra; Giovanni Pioggia; Sebastiano Gangemi
Journal:  Clin Transl Allergy       Date:  2022-03       Impact factor: 5.871

  7 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.